Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Presentation
Patrice Hugo, Ph.D. | February 09, 2018

Third Party Component Operational Aspects of PDL1 Stratification and Biomarkers

Immuno-Oncology 360° Conference Presentation
Presented during the Immuno-Oncology 360° conference, this presentation provides the third-party perspective on operational aspects of immuno-oncology trials, including PDL1 stratification and biomarkers. Q2 Solutions presented as part of a collaborative talk with a panel discussion.

Q2 Solutions has a unique role in immuno-oncology drug development, with clinical laboratory services continually evolving to provide clear results that meet regulatory standards and drive confident decisions for customers.

Download this presentation to learn more.

Speaker:
Patrice Hugo, Ph.D., Chief Scientific Officer

Panelists:
Howard Grossberg, MD, Senior Medical Director, Oncology Center of Excellence, IQVIA
Jeff Hodge, VP, Development Solutions, Oncology Center of Excellence, IQVIA

Related Services:
Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Biomarker Roadmap to Success

Develop a biomarker roadmap for a successful strategy in developing targeted therapies

The Power of the Central Laboratory for Immuno-Oncology Drug Development

Global Anatomic Pathology Solutions

Learn how we can advance your clinical trials

New Opportunities for Immuno-oncology Clinical Development Programs through T cell/B cell Repertoire Profiling

Immune repertoire profiling provides better outcomes for immuno-oncology development programs

Read More